Nuclear Medicine

MAA

Name:
Albumin Macroagregate

Active Principle:
Human Albumin Macroagregate

Therapeutic Action:
It is indicated for lung imaging by scintigraphy. It is used for:
– Assessment of pulmonary perfusion for the diagnosis or exclusion of pulmonary embolism
– Assessment of peritoneal-venous (LeVeen) shunt patency.
– Simultaneous explorations with treatments that result in a significant reduction in regional pulmonary perfusion.
– Preoperative studies of local pulmonary perfusion prior to a partial lung resection in a preoperative exploration.
– Monitoring the progress of lung transplants, as well as complementary pre-therapeutic examinations for radiotherapy planning. – Initial evaluation and follow-up of patients suffering from severe obstructive and/or restrictive lung diseases in combination with a ventilation scan.
– Diagnosis and quantification of right-to-left pulmonary shunts. It is also used as an alternative to Doppler ultrasound for lower extremity Phleboscintigraphy, in combination with pulmonary perfusion scintigraphy for patients suspected of having deep lower extremity phlebothrombosis and pulmonary embolism (venography). isotopic).

Línea

Nuclear Medicine

Sublínea

SPECT Radiopharmaceuticals

MAA

Línea

Nuclear Medicine

Sublínea

SPECT Radiopharmaceuticals

MAA

Nuclear Medicine

MAA

Name:
Albumin Macroagregate

Active Principle:
Human Albumin Macroagregate

Therapeutic Action:
It is indicated for lung imaging by scintigraphy. It is used for:
– Assessment of pulmonary perfusion for the diagnosis or exclusion of pulmonary embolism
– Assessment of peritoneal-venous (LeVeen) shunt patency.
– Simultaneous explorations with treatments that result in a significant reduction in regional pulmonary perfusion.
– Preoperative studies of local pulmonary perfusion prior to a partial lung resection in a preoperative exploration.
– Monitoring the progress of lung transplants, as well as complementary pre-therapeutic examinations for radiotherapy planning. – Initial evaluation and follow-up of patients suffering from severe obstructive and/or restrictive lung diseases in combination with a ventilation scan.
– Diagnosis and quantification of right-to-left pulmonary shunts. It is also used as an alternative to Doppler ultrasound for lower extremity Phleboscintigraphy, in combination with pulmonary perfusion scintigraphy for patients suspected of having deep lower extremity phlebothrombosis and pulmonary embolism (venography). isotopic).

RELATED PRODUCTS